Omnicell (OMCL) Reports Q2 EPS of $0.17, Beats by a Penny
More News related to OMCL
- Omnicell to Present at Thomas Weisel Partners Healthcare Conference
- Omnicell Reports Second Quarter 2008 Results
- Omnicell (OMCL) Reports Q2 EPS of $0.17, Beats by a Penny
- Omnicell OptiFlex CL Automates Cath Lab Supply Tracking at St. Patrick Hospital
- Omnicell Helps Hospitals Reduce Inefficiencies and Inventory Costs in Hospital Speciality Areas With New Automated Wireless Supply Mobile Cart
More News related to Earnings
- Shiloh Industries (SHLO) Tops Q3 EPS View By 12c
- National Semiconductor (NSM) Reports Q1 EPS of $0.33; Guides Q2 Sales
- Aceto Corp. (ACET) Reports Q4 EPS of $0.32
- Sycamore Networks (SCMR) Misses Q4 Revenue View By $10M
- ABM Industries (ABM) Reports Higher Q3 Earnings; Narrows FY08 Guidance
Omnicell, Inc. (Nasdaq: OMCL) reports Q2 EPS of $0.17, 1 cent better than the analyst estimate of $0.16. Revenues for the quarter were $63.4 million, versus the consensus of $62.01 million.
Omnicell, Inc. provides medication control and patient safety solutions for acute care health facilities.
Related Categories
EarningsStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
